Global Contraceptives Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Contraceptives Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Contraceptives report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Contraceptives market is projected to reach US$ 2277.4 million in 2034, increasing from US$ 1911.9 million in 2022, with the CAGR of 2.5% during the period of 2024 to 2034. Demand from 15–24 years and 25–34 years are the major drivers for the industry.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Contraceptives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, End User and Regions Listed in the Report
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Segment by Type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
Segment by End User
15–24 years
25–34 years
35–44 years
Above 44 years
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Contraceptives market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Contraceptives, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Contraceptives industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Contraceptives in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product End User, Volume and Revenue analysis of Each End User in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Contraceptives introduction, etc. Contraceptives Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Contraceptives market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Contraceptives report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Contraceptives market is projected to reach US$ 2277.4 million in 2034, increasing from US$ 1911.9 million in 2022, with the CAGR of 2.5% during the period of 2024 to 2034. Demand from 15–24 years and 25–34 years are the major drivers for the industry.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Contraceptives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, End User and Regions Listed in the Report
By Company
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Segment by Type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
Segment by End User
15–24 years
25–34 years
35–44 years
Above 44 years
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Contraceptives market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Contraceptives, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Contraceptives industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Contraceptives in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product End User, Volume and Revenue analysis of Each End User in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Contraceptives introduction, etc. Contraceptives Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Contraceptives market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.